Pandion Therapeutics Inc
NASDAQ:PAND (3/31/2021, 7:12:53 PM)
After market: 60.05 0 (0%)60.05
+0.13 (+0.22%)
Pandion Therapeutics Inc. is a biotechnology company. It focuses on developing modular proteins, antibodies and bispecifics for the treatment of autoimmune and inflammatory diseases. Pandion Therapeutics Inc. is based in North Cambridge, United States.
Pandion Therapeutics Inc
134 COOLIDGE AVENUE 2ND FLOOR
WATERTOWN MA 02472
P: 617-393-5925
CEO: Rahul Kakkar
The pandemic forced millions of people to share working spaces with their partners or spouses while shut in their homes. For some, such as former FBI trainee Seth Markin, the close proximity led to temptation.
Here you can normally see the latest stock twits on PAND, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: